State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis

被引：25

作者：

Hoppe, JE ^{[1
]}

机构：

[1] Univ Tubingen, Kinderklin, D-72070 Tubingen, Germany

来源：

INFECTION | 1998年 / 26卷 / 04期

关键词：

D O I：

10.1007/BF02962373

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：242 / 246

页数：5

共 48 条

[1] Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin [J].

Aoyama, T ;

Sunakawa, K ;

Iwata, S ;

Takeuchi, Y ;

Fujii, R .

JOURNAL OF PEDIATRICS, 1996, 129 (05) :761-764

[2] SUSCEPTIBILITY OF BORDETELLA-PERTUSSIS TO 5 QUINOLONE ANTIMICROBIC DRUGS [J].

APPLEMAN, ME ;

HADFIELD, TL ;

GAINES, JK ;

WINN, RE .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 8 (02) :131-133

[3] INVITRO AND INVIVO ACTIVITIES OF QA-241, A NEW TRICYCLIC QUINOLONE DERIVATIVE [J].

ASAHARA, M ;

TSUJI, A ;

GOTO, S ;

MASUDA, K ;

KIUCHI, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1144-1152

[4]

BACE A, 1998, 4 INT C MACR AZ STRE, P58

[5] THE EFFECT OF CHARCOAL ON MICS FOR LEGIONELLA [J].

BARKER, J ;

FARRELL, ID .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (01) :127-127

[6] PERTUSSIS - CURRENT STATUS OF PREVENTION AND TREATMENT [J].

BASS, JW .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (06) :614-619

[7] ANTIBACTERIAL ACTIVITY OF CEFPODOXIME IN COMPARISON WITH CEFIXIME, CEFDINIR, CEFETAMET, CEFTIBUTEN, LORACARBEF, CEFPROZIL, BAY-3522, CEFUROXIME, CEFACLOR AND CEFADROXIL [J].

BAUERNFEIND, A ;

JUNGWIRTH, R .

INFECTION, 1991, 19 (05) :353-362

[8] RU-29-246, THE ACTIVE COMPOUND OF THE CEPHALOSPORIN-PRODRUG-ESTER HR-916 .1. ANTIBACTERIAL ACTIVITY INVITRO [J].

BAUERNFEIND, A ;

JUNGWIRTH, R ;

EBERLEIN, E ;

KLESEL, N ;

ADAM, F ;

ISERT, D ;

LIMBERT, M ;

MARKUS, A ;

SCHRINNER, E ;

SEIBERT, G .

JOURNAL OF ANTIBIOTICS, 1992, 45 (04) :505-520

[9] COMPARATIVE INVITRO ACTIVITIES OF THE NEW QUINOLONE, BAY-Y-3118, AND CIPROFLOXACIN, SPARFLOXACIN, TOSUFLOXACIN, CI-960 AND CI-990 [J].

BAUERNFEIND, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (04) :505-522

[10] INVITRO ACTIVITY AND STABILITY AGAINST NOVEL BETA-LACTAMASES OF INVESTIGATIONAL BETA-LACTAMS (CEFEPIME, CEFPIROME, FLOMOXEF, SCE-2787 AND PIPERACILLIN PLUS TAZOBACTAM) IN COMPARISON WITH ESTABLISHED COMPOUNDS (CEFOTAXIME, LATAMOXEF AND PIPERACILLIN) [J].

BAUERNFEIND, A ;

SCHWEIGHART, S ;

EBERLEIN, E ;

JUNGWIRTH, R .

INFECTION, 1991, 19 :S264-S275

← 1 2 3 4 5 →